Yilmaz Emre Gencay

5PUBLICATIONS
23CO-AUTHORS
Medical bacteriologyPharmacogenomicsMedical infection agents (incl. prions)Host-parasite interactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 11, 2026
First-in-Human Adjunctive Bacteriophage Therapy for Malakoplakia.

|Oct 09, 2024
Campycins are novel broad-spectrum antibacterials killing Campylobacter jejuni.

Athina Zampara, Yilmaz Emre Gencay, Lone Brøndsted

|May 04, 2023
Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice.

Yilmaz Emre Gencay, Džiuginta Jasinskytė, Camille Robert

|Jul 26, 2020
Phage S144, A New Polyvalent Phage Infecting Salmonella spp. and Cronobacter sakazakii.

Michela Gambino, Anders Nørgaard Sørensen, Stephen Ahern

|Mar 20, 2019
The genera of bacteriophages and their receptors are the major determinants of host range.

Yilmaz Emre Gencay, Michela Gambino, Tessa From Prüssing

Pageof 1